Has the circulating permeability factor in primary FSGS been found?

Kidney International

Volumn 84, Issue 2, 2013, Pages 235-238

  Ashley Jefferson, J ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 3; VITRONECTIN RECEPTOR;

ANALYTIC METHOD; CAUSAL ATTRIBUTION; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; MECHANICAL STRESS; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SENSITIVITY AND SPECIFICITY;

FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84881149499     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.204     Document Type: Note

References (9)

1. McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5: 2115-2121.
2. Wei C, El Hindi S, Li J et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952-960.
3. Wei C, Moller CC, Altintas MM et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14: 55-63.
4. Wei C, Trachtman H, Li J et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23: 2051-2059.
5. Furlan F, Orlando S, Laudanna C et al. The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J Cell Sci 2004; 117: 2909-2916. (Pubitemid 39117666)
6. Kemper MJ, Wei C, Reiser J. Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis 2013; 61: 352.
7. Huang J, Liu G, Zhang Y-M et al. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 2013; 84: 366-372.
8. Maas RJ, Wetzels JF, Deegens JK. Serumsoluble urokinase receptor concentration in primary FSGS. Kidney Int 2012; 81: 1043-1044.
9. Thuno M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009; 27: 157-172.